Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

Recruiting N/A Interventional Study
Ventricular Tachycardias Myocardial Infarction (MI) Implantable Cardiac Defibrillator Ablation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
220 (estimated)
Sponsor
MEDICOVER SP Z O.O. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Status after myocardial infarction (minimum 3 months before inclusion in the study). * Documented post-infarction VT or VF. * Implantable ICD (at least 2 weeks before ablation) or CRT-D (at least 2 months before ablation). * A history of at least one from below: 1. One or m…
Contacts

Derejko P Prof. Paweł Derejko, MD, PhD

+48 603338871

pawel.derejko@medicover.pl

CONTACT

Fabijańska M Project Manager for Clinical Trials in Medicover Hospital

+48 519532444

magdalena.fabijanska@medicover.pl

CONTACT